These days are very exciting, but the question is will we reach the endpoint next year? The number of samples in the phase 2 is too small, and the eGFR was added in the phase3. Considering the failure of dkd, any thoughts？
News: DXB Dimerix Ltd Entered Into Exclusive License Agreement, page-7
Add DXB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
38.0¢ |
Change
0.015(4.11%) |
Mkt cap ! $211.6M | |||
| Open | High | Low | Value | Volume |
| 37.0¢ | 39.0¢ | 36.5¢ | $822.1K | 2.156M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 174062 | 37.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 38.0¢ | 29612 | 1 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| DXB (ASX) Chart |